OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mitochondria determine response to anti-programmed cell death protein-1 (anti-PD-1) immunotherapy: An evidence-based hypothesis
Hassan Akbari, Farzad Taghizadeh‐Hesary, Moslem Bahadori
Mitochondrion (2021) Vol. 62, pp. 151-158
Open Access | Times Cited: 32
Hassan Akbari, Farzad Taghizadeh‐Hesary, Moslem Bahadori
Mitochondrion (2021) Vol. 62, pp. 151-158
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Role of mitochondrial alterations in human cancer progression and cancer immunity
Sheng‐Fan Wang, Ling‐Ming Tseng, Hsin‐Chen Lee
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 62
Sheng‐Fan Wang, Ling‐Ming Tseng, Hsin‐Chen Lee
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 62
Mitochondrial immune regulation and anti-tumor immunotherapy strategies targeting mitochondria
Rilan Bai, Jiuwei Cui
Cancer Letters (2023) Vol. 564, pp. 216223-216223
Open Access | Times Cited: 33
Rilan Bai, Jiuwei Cui
Cancer Letters (2023) Vol. 564, pp. 216223-216223
Open Access | Times Cited: 33
Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity
Farzad Taghizadeh‐Hesary, Mohammad Houshyari, Mohammad Farhadi
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 9, pp. 6719-6741
Closed Access | Times Cited: 29
Farzad Taghizadeh‐Hesary, Mohammad Houshyari, Mohammad Farhadi
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 9, pp. 6719-6741
Closed Access | Times Cited: 29
Mitochondrial Metabolism: A New Dimension of Personalized Oncology
Babak Behnam, Farzad Taghizadeh‐Hesary
Cancers (2023) Vol. 15, Iss. 16, pp. 4058-4058
Open Access | Times Cited: 25
Babak Behnam, Farzad Taghizadeh‐Hesary
Cancers (2023) Vol. 15, Iss. 16, pp. 4058-4058
Open Access | Times Cited: 25
Targeted Anti-Mitochondrial Therapy: The Future of Oncology
Farzad Taghizadeh‐Hesary, Hassan Akbari, Moslem Bahadori, et al.
Genes (2022) Vol. 13, Iss. 10, pp. 1728-1728
Open Access | Times Cited: 36
Farzad Taghizadeh‐Hesary, Hassan Akbari, Moslem Bahadori, et al.
Genes (2022) Vol. 13, Iss. 10, pp. 1728-1728
Open Access | Times Cited: 36
The genetic landscape and possible therapeutics of neurofibromatosis type 2
Mohammad Amin Ghalavand, Alimohamad Asghari, Mohammad Farhadi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 21
Mohammad Amin Ghalavand, Alimohamad Asghari, Mohammad Farhadi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 21
Is Mitochondrial Metabolism a New Predictive Biomarker for Antiprogrammed Cell Death Protein-1 Immunotherapy?
Mohammad Houshyari, Farzad Taghizadeh‐Hesary
JCO Oncology Practice (2022) Vol. 19, Iss. 3, pp. 123-124
Open Access | Times Cited: 28
Mohammad Houshyari, Farzad Taghizadeh‐Hesary
JCO Oncology Practice (2022) Vol. 19, Iss. 3, pp. 123-124
Open Access | Times Cited: 28
Evaluating the influence of sarcopenia and myosteatosis on clinical outcomes in gastric cancer patients undergoing immune checkpoint inhibitor
Guiming Deng, Haibin Song, Zhongze Du, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 8, pp. 863-880
Open Access | Times Cited: 4
Guiming Deng, Haibin Song, Zhongze Du, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 8, pp. 863-880
Open Access | Times Cited: 4
Severe Intra- and Post-Operative Lactic Acidosis in a Patient Who Underwent Robotic Thoracoscopic Surgery
Alexander Smirnov, Michael Semionov, Shlomo Yaron Ishay, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 568-568
Open Access
Alexander Smirnov, Michael Semionov, Shlomo Yaron Ishay, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 568-568
Open Access
Igniting Hope for Tumor Immunotherapy: Promoting the “Hot and Cold” Tumor Transition
Wei Chen, Yichao Ma, Fei Wang, et al.
Clinical Medicine Insights Oncology (2022) Vol. 16
Open Access | Times Cited: 17
Wei Chen, Yichao Ma, Fei Wang, et al.
Clinical Medicine Insights Oncology (2022) Vol. 16
Open Access | Times Cited: 17
Lung cancer prediction using machine learning on data from a symptom e-questionnaire for never smokers, formers smokers and current smokers
Elinor Nemlander, Andreas Rosenblad, Eliya Abedi, et al.
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0276703-e0276703
Open Access | Times Cited: 14
Elinor Nemlander, Andreas Rosenblad, Eliya Abedi, et al.
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0276703-e0276703
Open Access | Times Cited: 14
Anti-mitochondrial Therapy: A Potential Therapeutic Approach in Oncology
Farzad Taghizadeh‐Hesary, Hassan Akbari, Moslem Bahadori
(2022)
Open Access | Times Cited: 13
Farzad Taghizadeh‐Hesary, Hassan Akbari, Moslem Bahadori
(2022)
Open Access | Times Cited: 13
Clinical Characteristics and Outcomes of COVID-19 in 1294 New Cancer Patients: Single-Center, Prospective Cohort Study from Iran
Danial Fazilat‐Panah, Hamid Fallah Tafti, Yavar Rajabzadeh, et al.
Cancer Investigation (2022) Vol. 40, Iss. 6, pp. 505-515
Closed Access | Times Cited: 13
Danial Fazilat‐Panah, Hamid Fallah Tafti, Yavar Rajabzadeh, et al.
Cancer Investigation (2022) Vol. 40, Iss. 6, pp. 505-515
Closed Access | Times Cited: 13
Targeted Anti-mitochondrial Therapy: The Future of Oncology
Farzad Taghizadeh‐Hesary, Babak Behnam, Hassan Akbari, et al.
(2022)
Open Access | Times Cited: 12
Farzad Taghizadeh‐Hesary, Babak Behnam, Hassan Akbari, et al.
(2022)
Open Access | Times Cited: 12
Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: a case report
Takayoshi Fuu, Kazuyoshi Iijima, Yukiko Kusama, et al.
Journal of Medical Case Reports (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Takayoshi Fuu, Kazuyoshi Iijima, Yukiko Kusama, et al.
Journal of Medical Case Reports (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 9
[Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancer
Linfeng Luo, Anlin Li, Sha Fu, et al.
Immunologic Research (2022) Vol. 71, Iss. 2, pp. 213-228
Closed Access | Times Cited: 9
Linfeng Luo, Anlin Li, Sha Fu, et al.
Immunologic Research (2022) Vol. 71, Iss. 2, pp. 213-228
Closed Access | Times Cited: 9
Anti-mitochondrial Therapy: A New Dimension of Personalized Oncology
Babak Behnam, Farzad Taghizadeh‐Hesary
(2023)
Open Access | Times Cited: 5
Babak Behnam, Farzad Taghizadeh‐Hesary
(2023)
Open Access | Times Cited: 5
Development and Validation of a Predictive Nomogram with Age and Laboratory Findings for Severe COVID-19 in Hunan Province, China
Junyi Jiang, Weijun Zhong, Wei‐Hua Huang, et al.
Therapeutics and Clinical Risk Management (2022) Vol. Volume 18, pp. 579-591
Open Access | Times Cited: 5
Junyi Jiang, Weijun Zhong, Wei‐Hua Huang, et al.
Therapeutics and Clinical Risk Management (2022) Vol. Volume 18, pp. 579-591
Open Access | Times Cited: 5
Overexpression of LIMA1 Indicates Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
Wei Ma, Yiqun Liao, Ziwen Gao, et al.
Clinical Medicine Insights Oncology (2022) Vol. 16
Open Access | Times Cited: 5
Wei Ma, Yiqun Liao, Ziwen Gao, et al.
Clinical Medicine Insights Oncology (2022) Vol. 16
Open Access | Times Cited: 5
Effect of Physical Activity and Exercise on the Level of COVID-19 Antibodies and Lifestyle-Related Factors among Vaccinated Health Science Center (HSC) Students: A Pilot Randomized Trial
Abdulaziz M. F. Shayea, Naser Alotaibi, Mohammed Shaban Nadar, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2171-2171
Open Access | Times Cited: 5
Abdulaziz M. F. Shayea, Naser Alotaibi, Mohammed Shaban Nadar, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2171-2171
Open Access | Times Cited: 5
Recurrent primary intracranial synovial sarcoma, a case report and review of the literature
Ataee Kachuee Manizhe, Iman Mohseni, Alireza Sahranavard, et al.
Clinical Case Reports (2022) Vol. 10, Iss. 9
Open Access | Times Cited: 3
Ataee Kachuee Manizhe, Iman Mohseni, Alireza Sahranavard, et al.
Clinical Case Reports (2022) Vol. 10, Iss. 9
Open Access | Times Cited: 3
Energy-Pollution-Health-Economy Nexus Study in Southeast Asia
Farhad Taghizadeh‐Hesary, Farzad Taghizadeh‐Hesary
(2023), pp. 739-760
Closed Access | Times Cited: 1
Farhad Taghizadeh‐Hesary, Farzad Taghizadeh‐Hesary
(2023), pp. 739-760
Closed Access | Times Cited: 1
Dynamic changes in intrinsic subtype, immunity status, and risk score before and after neoadjuvant chemo- and HER2-targeted therapy without pCR in HER2-positive breast cancers: A cross-sectional analysis
Peixian Chen, Xiaofan Mao, Na Ma, et al.
Medicine (2022) Vol. 101, Iss. 31, pp. e29877-e29877
Open Access | Times Cited: 2
Peixian Chen, Xiaofan Mao, Na Ma, et al.
Medicine (2022) Vol. 101, Iss. 31, pp. e29877-e29877
Open Access | Times Cited: 2
A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 Immunotherapy
Emma Bigelow, Suchi Saria, Brian Piening, et al.
Cancer Informatics (2022) Vol. 21
Open Access | Times Cited: 2
Emma Bigelow, Suchi Saria, Brian Piening, et al.
Cancer Informatics (2022) Vol. 21
Open Access | Times Cited: 2
Immune Cells vs. Cancer Cells: A Microscopic Energy Battle
Farzad Taghizadeh‐Hesary, Hassan Akbari, Moslem Bahadori
(2022)
Open Access | Times Cited: 1
Farzad Taghizadeh‐Hesary, Hassan Akbari, Moslem Bahadori
(2022)
Open Access | Times Cited: 1
